Læknaneminn - 01.01.2017, Page 31

Ri
trý
nt
ef
ni
3030
1. Leibowitz HM. The Red Eye. N Engl J Med.
Massachusetts Medical Society; 2000 Aug
3;343(5):345–51.
2. Petersen I, Hayward AC. Antibacterial
prescribing in primary care. J Antimicrob
Chemother. England; 2007 Aug;60 Suppl
1:i43­47.
3. AA A, NP B. Conjunctivitis: A systematic
review of diagnosis and treatment. JAMA.
2013 Oct 23;310(16):1721–30.
4. Augnsýkingar af völdum adenóveira [Internet].
Embætti Landlæknis. 2016 [cited 2017 Jan
1]. Available from: http://www.landlaeknir.is/
smit­og­sottvarnir/smitsjukdomar/sjukdomur/
item12463/Augnsykingar­af­voldum­
adenoveira
5. Roba LA, Kowalski RP, Gordon AT,
Romanowski EG, Gordon YJ. Adenoviral
ocular isolates demonstrate serotype­
dependent differences in in vitro infectivity
titers and clinical course. Cornea. United
States; 1995 Jul;14(4):388–93.
6. Cronau H, Kankanala RR, Mauger T.
Diagnosis and management of red eye in
primary care. Am Fam Physician. United
States; 2010 Jan;81(2):137–44.
7. Noble J, Lloyd JC. The red eye. CMAJ.
2011;183(1):81.
8. Leibowitz HM. The red eye. N Engl J Med.
United States; 2000 Aug;343(5):345–51.
9. Jernigan JA, Lowry BS, Hayden FG, Kyger SA,
Conway BP, Groschel DH, et al. Adenovirus
type 8 epidemic keratoconjunctivitis in an eye
clinic: risk factors and control. J Infect Dis.
United States; 1993 Jun;167(6):1307–13.
10. Hovding G. Acute bacterial conjunctivitis.
Acta Ophthalmol. England; 2008 Feb;86(1):5–
17.
11. Morrow GL, Abbott RL. Conjunctivitis.
Am Fam Physician. United States; 1998
Feb;57(4):735–46.
12. Lee JS, Choi HY, Lee JE, Lee SH, Oum BSS.
Gonococcal keratoconjunctivitis in adults.
Eye. Royal College of Ophthalmologists; 2002
Sep;16(5):646–9.
13. Faggian F, Azzini A, Lanzafame M, Bonora A,
Zorzi A, Concia E, et al. Hyperacute unilateral
gonococcal endophthalmitis in an HIV­
infected man without genital infection. Eur J
Ophthalmol. Italy; 2006;16(2):346–8.
14. Wan WL, Farkas GC, May WN, Robin JB.
The clinical characteristics and course of adult
gonococcal conjunctivitis. Am J Ophthalmol.
United States; 1986 Nov;102(5):575–83.
15. Rietveld RP, Riet G ter, Bindels PJE, Sloos
JH, van Weert HCPM. Predicting bacterial
cause in infectious conjunctivitis: cohort study
on informativeness of combinations of signs
and symptoms. BMJ : British Medical Journal.
2004. p. 206–10.

16. Rose PW, Harnden A, Brueggemann
AB, Perera R, Sheikh A, Crook D, et al.
Chloramphenicol treatment for acute infective
conjunctivitis in children in primary care: a
randomised double­blind placebo­controlled
trial. Lancet (London, England). England;
2005 Jul;366(9479):37–43.
17. Sheikh A, Hurwitz B. Topical antibiotics
for acute bacterial conjunctivitis: Cochrane
systematic review and meta­analysis update. Br
J Gen Pract. England; 2005 Dec;55(521):962–
4.
18. Wickstrom K. Acute bacterial conjunctivitis­­
benefits versus risks with antibiotic treatment.
Acta ophthalmologica. England; 2008. p. 2–4.
19. Jauch A, Fsadni M, Gamba G. Meta­analysis
of six clinical phase III studies comparing
lomefloxacin 0.3{%} eye drops twice daily to
five standard antibiotics in patients with acute
bacterial conjunctivitis. Graefe’s Arch Clin Exp
Ophthalmol. 1999;237(9):705–13.
20. Lohr JA, Austin RD, Grossman M, Hayden
GF, Knowlton GM, Dudley SM. Comparison
of three topical antimicrobials for acute
bacterial conjunctivitis. Pediatr Infect Dis J.
United States; 1988 Sep;7(9):626–9.
21. Ronnerstam R, Persson K. Chlamydial eye
infection in adults. Scand J Infect Dis Suppl.
England; 1982;32:111–5.
22. Bobo L, Viscidi R, Quinn T, West S,
Mkocha H, Munoz B. Diagnosis of
Chlamydia trachomatis eye infection in
Tanzania by polymerase chain reaction/
enzyme immunoassay. Lancet. 1991 Oct
5;338(8771):847–50.
23. Postema EJ, Remeijer L, van der Meijden WI.
Epidemiology of genital chlamydial infections
in patients with chlamydial conjunctivitis; a
retrospective study. Genitourin Med. 1996 Jun
1;72(3):203 LP­205.
24. Beem MO, Saxon E, Tipple MA. Treatment of
Chlamydial Pneumonia of Infancy. Pediatrics.
1979 Feb 1;63(2):198 LP­203.
25. Wright HR, Turner A, Taylor HR. Trachoma.
Lancet. 7AD Jun 13;371(9628):1945–54.
26. Trachoma [Internet]. World Health
Organization. 2016 [cited 2017 Feb 8].
Available from: http://www.who.int/
mediacentre/factsheets/fs382/en/
27. Burton MJ. Trachoma: an overview. Br Med
Bull. 2007;84(1):99.
28. Bielory L, Friedlaender MH. Allergic
Conjunctivitis. Immunol Allergy Clin.
Elsevier; 2017 Feb 8;28(1):43–58.
29. Ono SJ, Abelson MB. Allergic conjunctivitis:
Update on pathophysiology and prospects for
future treatment. J Allergy Clin Immunol.
2005 Jan;115(1):118–22.
30. Azari AA, Barney NP. Conjunctivitis:
a systematic review of diagnosis and
treatment. JAMA. United States; 2013
Oct;310(16):1721–9.

31. Brewitt H, Sistani F. Dry Eye Disease: The
Scale of the Problem. Surv Ophthalmol. 2001
Mar;45, Supple:S199–202.
32. Pflugfelder SC. Prevalence, burden, and
pharmacoeconomics of dry eye disease. Am J
Manag Care. United States; 2008 Apr;14(3
Suppl):S102­6.
33. Buchholz P, Steeds CS, Stern LS, Wiederkehr
DP, Doyle JJ, Katz LM, et al. Utility
assessment to measure the impact of dry
eye disease. Ocul Surf. United States; 2006
Jul;4(3):155–61.
34. Reddy P, Grad O, Rajagopalan K. The
economic burden of dry eye: a conceptual
framework and preliminary assessment.
Cornea. United States; 2004 Nov;23(8):751–
61.
35. Montes­Mico R. Role of the tear film in
the optical quality of the human eye. J
Cataract Refract Surg. United States; 2007
Sep;33(9):1631–5.
36. Liu Z, Pflugfelder SC. Corneal surface
regularity and the effect of artificial tears
in aqueous tear deficiency. Ophthalmology.
United States; 1999 May;106(5):939–43.
37. Lemp MA, Nichols KK. Blepharitis in
the United States 2009: A Survey­based
Perspective on Prevalence and Treatment. Ocul
Surf . 2009;7(2):S1–14.
38. Jackson WB. Blepharitis: current strategies
for diagnosis and management. Can J
Ophthalmol. England; 2008 Apr;43(2):170–9.
39. Sjónlag. Hvað orsakar hvarmabólgu og
hvað er til ráða gegn henni? [Internet].
Vísindavefurinn. 2014 [cited 2017 Feb 10].
Available from: http://visindavefur.is/svar.
php?id=7588
40. Liu J, Sheha H, Tseng SCG. Pathogenic role
of Demodex mites in blepharitis. Curr Opin
Allergy Clin Immunol. 2010 Oct;10(5):505–
10.
41. Tullo A. Pathogenesis and management of
herpes simplex virus keratitis. Eye (Lond).
England; 2003 Nov;17(8):919–22.
42. Turner A, Rabiu M. Patching for corneal
abrasion. Cochrane database Syst Rev.
England; 2006 Apr;(2):CD004764.
43. Peyman GA, Rahimy MH, Fernandes ML.
Effects of morphine on corneal sensitivity
and epithelial wound healing: implications for
topical ophthalmic analgesia. Br J Ophthalmol.
England; 1994 Feb;78(2):138–41.
44. Fukuyama J ­i., Hayasaka S, Yamada K,
Setogawa T. Causes of Subconjunctival
Hemorrhage. Ophthalmologica.
1990;200(2):63–7.
45. Williams CPR, Browning AC, Sleep TJ,
Webber SK, McGill JI. A randomised, double­
blind trial of topical ketorolac vs artificial tears
for the treatment of episcleritis. Eye (Lond).
England; 2005 Jul;19(7):739–42.
Heimildaskrá